IFNG and systemic lupus erythematosus: Later, a clinical study proved that higher baseline levels of IFN-γ might predict a good response to UCMSCs in SLE patients, indicating baseline levels of IFN-γ could be one of the biomarkers to establish the clinical inclusion/exclusion criteria for UCMSC application in SLE patients [42].